510(k) K221326

Nova Allegro HbA1c Assay, Nova Allegro Analyzer by Nova Biomedical Corporation — Product Code LCP

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
November 22, 2024
Date Received
May 6, 2022
Clearance Type
Dual Track
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Assay, Glycosylated Hemoglobin
Device Class
Class II
Regulation Number
864.7470
Review Panel
HE
Submission Type